Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KIROPRAKTISK KLINIK RENI KLAVSEN D.C. ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6%   Bankruptcy risk   2.2% 2.1% 4.2% 9.6% 2.4% 1.5% 13.3% 11.2%   Credit score (0-100)   68 70 50 25 62 75 16 22   Credit rating   BBB A BBB BB BBB A BB BB   Credit limit (kDKK)   0.1 0.2 0.0 0.0 0.0 7.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,257 1,140 1,067 1,157 1,376 1,285 0.0 0.0   EBITDA   780 668 221 582 825 689 0.0 0.0   EBIT   695 583 143 581 825 664 0.0 0.0   Pre-tax profit (PTP)   693.0 578.0 127.0 555.0 852.0 631.8 0.0 0.0   Net earnings   540.0 451.0 98.0 432.0 662.0 490.9 0.0 0.0   Pre-tax profit without non-rec. items   693 578 127 555 852 632 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   164 79.0 1.0 0.0 0.0 480 0.0 0.0   Shareholders equity total   1,443 1,495 1,192 1,224 1,486 1,577 1,052 1,052   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,567 1,618 1,305 1,518 1,684 1,696 1,052 1,052   Net Debt   -1,108 -1,332 -1,124 -1,490 -1,478 -997 -1,052 -1,052     See the entire balance sheet 1000.0 Volume  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,257 1,140 1,067 1,157 1,376 1,285 0.0 0.0   Gross profit growth   10.7% -9.3% -6.4% 8.4% 18.9% -6.6% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,567 1,618 1,305 1,518 1,684 1,696 1,052 1,052   Balance sheet change%   6.5% 3.3% -19.3% 16.3% 10.9% 0.7% -38.0% 0.0%   Added value   695.0 583.0 143.0 581.0 825.0 663.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -170 -170 -156 -2 0 455 -480 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   55.3% 51.1% 13.4% 50.2% 60.0% 51.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   45.8% 36.6% 9.8% 41.2% 54.5% 39.3% 0.0% 0.0%   ROI %   50.5% 39.7% 10.6% 48.1% 64.4% 42.9% 0.0% 0.0%   ROE %   39.3% 30.7% 7.3% 35.8% 48.9% 32.1% 0.0% 0.0%   1000.0 Solidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   92.1% 92.4% 91.3% 80.6% 88.2% 93.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -142.1% -199.4% -508.6% -256.0% -179.2% -144.8% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   10.3 11.0 10.9 5.2 7.6 13.2 0.0 0.0   Current Ratio   10.3 11.0 10.9 5.2 7.6 13.2 0.0 0.0   Cash and cash equivalent   1,108.0 1,332.0 1,124.0 1,490.0 1,478.0 997.1 0.0 0.0   1000.0 Capital use efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,155.0 1,234.0 1,084.0 1,205.0 1,264.0 941.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   695 583 143 581 825 664 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   780 668 221 582 825 689 0 0   EBIT / employee   695 583 143 581 825 664 0 0   Net earnings / employee   540 451 98 432 662 491 0 0